Gang Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gang Bao has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
Nitin Nitin
Georgia Institute of Technology and Emory University, Department of Biomedical Engineering, Atlanta, GA, USA, 30332
7 shared publicationsSheng Tong
Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30332, USA
7 shared publications- Thomas J. Cradick
Excision BioTherapeutics, Inc., San Francisco, USA
7 shared publications - Andrew Tsourkas
University of Pennsylvania
6 shared publications - Won Jong Rhee
Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea
6 shared publications - Eli J. Fine
Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA
5 shared publications
Latest Publications
- 18 March 2021
- Published by Springer Nature
- p. 237-251
Nanoprobes for Live-Cell Gene Detection
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (12) , 5527
Microtubule-Associated Protein Mdp3 Promotes Breast Cancer Growth and Metastasis (vol 4, pg 1052, 2014)
[This corrects the article DOI: 10.7150/thno.9727.].
- 1 January 2020
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (12) , 5527
Open AccessMicrotubule-Associated Protein Mdp3 Promotes Breast Cancer Growth and Metastasis (vol 4, pg 1052, 2014)
[This corrects the article DOI: 10.7150/thno.9727.].
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S54
131. Chromatin-Dependent Loci Accessibility Affects CRISPR-Cas9 Targeting Efficiency
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S54
Open Access131. Chromatin-Dependent Loci Accessibility Affects CRISPR-Cas9 Targeting Efficiency
- 4 March 2016
- Published by Springer Nature
- p. 187-222
Strategies to Determine Off-Target Effects of Engineered Nucleases
- 4 March 2016
- Published by Springer Nature
- p. 187-222
Strategies to Determine Off-Target Effects of Engineered Nucleases
- 1 May 2015
- Published by Elsevier in Biomaterials
- Vol. 50, 176-185
Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells
- 1 May 2015
- Published by Elsevier in Biomaterials
- Vol. 50, 176-185
Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells
- Open Access
- 1 January 2015
- Published by Ivyspring International Publisher in Theranostics
- Vol. 5 (7) , 656-666
CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism
Noscapine is an orally administrable drug used worldwide for cough suppression and has recently been demonstrated to disrupt microtubule dynamics and possess anticancer activity. However, the molecular mechanisms regulating noscapine activity remain poorly defined. Here we demonstrate that cylindromatosis (CYLD), a microtubule-associated tumor suppressor protein, modulates the activity of noscapine both in cell lines and in primary cells of acute lymphoblastic leukemia (ALL). Flow cytometry and immunofluorescence microscopy reveal that CYLD increases the ability of noscapine to induce mitotic arrest and apoptosis. Examination of cellular microtubules as well as in vitro assembled microtubules shows that CYLD enhances the effect of noscapine on microtubule polymerization. Microtubule cosedimentation and fluorescence titration assays further reveal that CYLD interacts with microtubule outer surface and promotes noscapine binding to microtubules. These findings thus demonstrate CYLD as a critical regulator of noscapine activity and have important implications for ALL treatment.
- 1 January 2015
- Published by Ivyspring International Publisher in Theranostics
- Vol. 5 (7) , 656-666
Open AccessCYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism
Noscapine is an orally administrable drug used worldwide for cough suppression and has recently been demonstrated to disrupt microtubule dynamics and possess anticancer activity. However, the molecular mechanisms regulating noscapine activity remain poorly defined. Here we demonstrate that cylindromatosis (CYLD), a microtubule-associated tumor suppressor protein, modulates the activity of noscapine both in cell lines and in primary cells of acute lymphoblastic leukemia (ALL). Flow cytometry and immunofluorescence microscopy reveal that CYLD increases the ability of noscapine to induce mitotic arrest and apoptosis. Examination of cellular microtubules as well as in vitro assembled microtubules shows that CYLD enhances the effect of noscapine on microtubule polymerization. Microtubule cosedimentation and fluorescence titration assays further reveal that CYLD interacts with microtubule outer surface and promotes noscapine binding to microtubules. These findings thus demonstrate CYLD as a critical regulator of noscapine activity and have important implications for ALL treatment.
- 18 September 2014
- Published by Springer Nature in Nature Protocols
- Vol. 9 (10) , 2411-2424
Molecular beacon–enabled purification of living cells by targeting cell type–specific mRNAs
Molecular beacons are dual-labeled oligonucleotides that fluoresce in the presence of complementary mRNA. This protocol describes how to use them to purify specific cell populations by targeting mRNAs that are highly expressed only in the desired cell type. Molecular beacons (MBs) are dual-labeled oligonucleotides that fluoresce only in the presence of complementary mRNA. The use of MBs to target specific mRNAs allows sorting of specific cells from a mixed cell population. In contrast to existing approaches that are limited by available surface markers or selectable metabolic characteristics, the MB-based method enables the isolation of a wide variety of cells. For example, the ability to purify specific cell types derived from pluripotent stem cells (PSCs) is important for basic research and therapeutics. In addition to providing a general protocol for MB design, validation and nucleofection into cells, we describe how to isolate a specific cell population from differentiating PSCs. By using this protocol, we have successfully isolated cardiomyocytes differentiated from mouse or human PSCs (hPSCs) with ∼97% purity, as confirmed by electrophysiology and immunocytochemistry. After designing MBs, their ordering and validation requires 2 weeks, and the isolation process requires 3 h.
- 18 September 2014
- Published by Springer Nature in Nature Protocols
- Vol. 9 (10) , 2411-2424
Molecular beacon–enabled purification of living cells by targeting cell type–specific mRNAs
Molecular beacons are dual-labeled oligonucleotides that fluoresce in the presence of complementary mRNA. This protocol describes how to use them to purify specific cell populations by targeting mRNAs that are highly expressed only in the desired cell type. Molecular beacons (MBs) are dual-labeled oligonucleotides that fluoresce only in the presence of complementary mRNA. The use of MBs to target specific mRNAs allows sorting of specific cells from a mixed cell population. In contrast to existing approaches that are limited by available surface markers or selectable metabolic characteristics, the MB-based method enables the isolation of a wide variety of cells. For example, the ability to purify specific cell types derived from pluripotent stem cells (PSCs) is important for basic research and therapeutics. In addition to providing a general protocol for MB design, validation and nucleofection into cells, we describe how to isolate a specific cell population from differentiating PSCs. By using this protocol, we have successfully isolated cardiomyocytes differentiated from mouse or human PSCs (hPSCs) with ∼97% purity, as confirmed by electrophysiology and immunocytochemistry. After designing MBs, their ordering and validation requires 2 weeks, and the isolation process requires 3 h.
- Open Access
- 16 May 2014
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (11) , 7473-7485
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences
CRISPR/Cas9 systems are a versatile tool for genome editing due to the highly efficient targeting of DNA sequences complementary to their RNA guide strands. However, it has been shown that RNA-guided Cas9 nuclease cleaves genomic DNA sequences containing mismatches to the guide strand. A better understanding of the CRISPR/Cas9 specificity is needed to minimize off-target cleavage in large mammalian genomes. Here we show that genomic sites could be cleaved by CRISPR/Cas9 systems when DNA sequences contain insertions (‘DNA bulge’) or deletions (‘RNA bulge’) compared to the RNA guide strand, and Cas9 nickases used for paired nicking can also tolerate bulges in one of the guide strands. Variants of single-guide RNAs (sgRNAs) for four endogenous loci were used as model systems, and their cleavage activities were quantified at different positions with 1- to 5-bp bulges. We further investigated 114 putative genomic off-target loci of 27 different sgRNAs and confirmed 15 off-target sites, each harboring a single-base bulge and one to three mismatches to the guide strand. Our results strongly indicate the need to perform comprehensive off-target analysis related to DNA and sgRNA bulges in addition to base mismatches, and suggest specific guidelines for reducing potential off-target cleavage.
- 16 May 2014
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (11) , 7473-7485
Open AccessCRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences
CRISPR/Cas9 systems are a versatile tool for genome editing due to the highly efficient targeting of DNA sequences complementary to their RNA guide strands. However, it has been shown that RNA-guided Cas9 nuclease cleaves genomic DNA sequences containing mismatches to the guide strand. A better understanding of the CRISPR/Cas9 specificity is needed to minimize off-target cleavage in large mammalian genomes. Here we show that genomic sites could be cleaved by CRISPR/Cas9 systems when DNA sequences contain insertions (‘DNA bulge’) or deletions (‘RNA bulge’) compared to the RNA guide strand, and Cas9 nickases used for paired nicking can also tolerate bulges in one of the guide strands. Variants of single-guide RNAs (sgRNAs) for four endogenous loci were used as model systems, and their cleavage activities were quantified at different positions with 1- to 5-bp bulges. We further investigated 114 putative genomic off-target loci of 27 different sgRNAs and confirmed 15 off-target sites, each harboring a single-base bulge and one to three mismatches to the guide strand. Our results strongly indicate the need to perform comprehensive off-target analysis related to DNA and sgRNA bulges in addition to base mismatches, and suggest specific guidelines for reducing potential off-target cleavage.
- Open Access
- 8 February 2014
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 42 (2) , 241-2
Frontiers in bioengineering research.
- 8 February 2014
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 42 (2) , 241-2
Open AccessFrontiers in bioengineering research.
- Open Access
- 16 January 2014
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (6) , e47
SAPTA: a new design tool for improving TALE nuclease activity
Transcription activator-like effector nucleases (TALENs) have become a powerful tool for genome editing due to the simple code linking the amino acid sequences of their DNA-binding domains to TALEN nucleotide targets. While the initial TALEN-design guidelines are very useful, user-friendly tools defining optimal TALEN designs for robust genome editing need to be developed. Here we evaluated existing guidelines and developed new design guidelines for TALENs based on 205 TALENs tested, and established the scoring algorithm for predicting TALEN activity (SAPTA) as a new online design tool. For any input gene of interest, SAPTA gives a ranked list of potential TALEN target sites, facilitating the selection of optimal TALEN pairs based on predicted activity. SAPTA-based TALEN designs increased the average intracellular TALEN monomer activity by >3-fold, and resulted in an average endogenous gene-modification frequency of 39% for TALENs containing the repeat variable di-residue NK that favors specificity rather than activity. It is expected that SAPTA will become a useful and flexible tool for designing highly active TALENs for genome-editing applications. SAPTA can be accessed via the website at http://baolab.bme.gatech.edu/Research/BioinformaticTools/TAL_targeter.html.
- 16 January 2014
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (6) , e47
Open AccessSAPTA: a new design tool for improving TALE nuclease activity
Transcription activator-like effector nucleases (TALENs) have become a powerful tool for genome editing due to the simple code linking the amino acid sequences of their DNA-binding domains to TALEN nucleotide targets. While the initial TALEN-design guidelines are very useful, user-friendly tools defining optimal TALEN designs for robust genome editing need to be developed. Here we evaluated existing guidelines and developed new design guidelines for TALENs based on 205 TALENs tested, and established the scoring algorithm for predicting TALEN activity (SAPTA) as a new online design tool. For any input gene of interest, SAPTA gives a ranked list of potential TALEN target sites, facilitating the selection of optimal TALEN pairs based on predicted activity. SAPTA-based TALEN designs increased the average intracellular TALEN monomer activity by >3-fold, and resulted in an average endogenous gene-modification frequency of 39% for TALENs containing the repeat variable di-residue NK that favors specificity rather than activity. It is expected that SAPTA will become a useful and flexible tool for designing highly active TALENs for genome-editing applications. SAPTA can be accessed via the website at http://baolab.bme.gatech.edu/Research/BioinformaticTools/TAL_targeter.html.